VALNEVA (EPA:VLA) | Finanzwire

PRESS RELEASE

published on 07/17/2024 at 22:00, 1 year 9 months ago

Phase 3 VALOR Lyme Disease Trial: Valneva and Pfizer Announce Primary Vaccination Series Completion
Phase 3 VALOR Lyme Disease Trial: Pfizer and Valneva announce completion of primary vaccination series with VLA15, progressing towards a Lyme disease vaccine

Valneva Lyme Disease Vaccine Pfizer VLA15 VALOR
BRIEF

published on 06/05/2024 at 07:05, 1 year 10 months ago

Valneva Announces Availability of Documentation for its Combined Shareholder Meeting and Provides Corporate Update

Executive Changes Corporate Update Valneva Shareholder Meeting
PRESS RELEASE

published on 06/05/2024 at 07:00, 1 year 10 months ago

Valneva Announces Availability of Documentation for its Combined Shareholder Meeting and Provides Corporate Update
Valneva announces availability of documentation for its Combined Shareholder Meeting on June 26, 2024, along with corporate update including change in General Counsel & Corporate Secretary. Kendra Wergin appointed as successor

Corporate Update Valneva General Counsel Shareholder Meeting Kendra Wergin
BRIEF

published on 05/21/2024 at 07:05, 1 year 11 months ago

Valneva appoints Dr Hanneke Schuitemaker as Scientific Director

Nomination R&D Valneva Vaccines Dr Hanneke Schuitemaker
BRIEF

published on 04/12/2024 at 10:42, 2 years ago

Upbeat Valneva Research Update from First Berlin Equity Research Maintains BUY Rating

First Berlin Equity Research Buy Recommendation Financial Strategy Valneva Lyme Disease Vaccine
PRESS RELEASE

published on 04/12/2024 at 10:37, 2 years ago

Original-Research: Valneva (von First Berlin Equity Research GmbH): Buy
First Berlin Equity Research reaffirms Buy rating on Valneva with a target price of €8.60, following positive guidance revisions and debt extension

First Berlin Equity Research BUY Rating Debt Extension Valneva EUR 8.60
BRIEF

published on 02/27/2024 at 16:01, 2 years 2 months ago

First Berlin updates its recommendation on Valneva with an adjusted price target

First Berlin Equity Research Purchase Recommendation Valneva Simon Scholes Course Objective
PRESS RELEASE

published on 02/27/2024 at 16:01, 2 years 2 months ago

Original-Research: Valneva (von First Berlin Equity Research GmbH): Buy
First Berlin Equity Research GmbH updates Valneva SE research report, reiterating Buy recommendation with a target price of €8.60 based on strong FY/23 product revenue recovery and positive outlook for travel vaccines and future prospects

Buy Recommendation Research Update Target Price Valneva SE Product Revenue
PRESS RELEASE

published on 10/12/2023 at 10:11, 2 years 6 months ago

Original-Research: Valneva (von First Berlin Equity Research GmbH): Buy
PRESS RELEASE

published on 05/22/2023 at 13:41, 2 years 11 months ago

Original-Research: Valneva (von First Berlin Equity Research GmbH): Buy

Published on 05/02/2026 at 01:30, 2 hours 29 minutes ago

Uraniumx Reports Strong Financial Position Ahead of Spring Drill Program
Published on 05/02/2026 at 00:50, 3 hours 9 minutes ago

CoTec Announces Annual Stock Option, Restricted Share Unit And Deferred Share Unit Grants
Published on 05/02/2026 at 00:00, 3 hours 59 minutes ago

Redwood AI Announces Enhanced AI Models, Increasing Evaluated Chemical Reactions Following Preliminary Results from UBC Collaboration
Published on 05/02/2026 at 00:00, 3 hours 59 minutes ago

Onco-Innovations Expands Manufacturing Scale-Up of Its PNKP Inhibitor Technology with Dalton Pharma Services, Advancing Multi-Kilogram Non-GMP Synthesis to Support IND-Enabling Studies
Published on 05/01/2026 at 22:30, 5 hours 29 minutes ago

Nextech3D.ai Appoints New Independent Auditor

View all ACCESSWIRE

Published on 05/01/2026 at 19:23, 8 hours 36 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 05/01/2026 at 18:40, 9 hours 19 minutes ago

Holding(s) in Company
Published on 05/01/2026 at 17:47, 10 hours 12 minutes ago

Key Figures 30.04.2026
Published on 05/01/2026 at 17:45, 10 hours 14 minutes ago

Burkhalter Group acquires Progressio Holding GmbH and anplaq ag, Tamins (GR)
Published on 05/01/2026 at 17:21, 10 hours 38 minutes ago

Fuller, Smith & Turner PLC: Total Voting Rights and Treasury Shares

View all EQS

Published on 04/30/2026 at 20:00, 1 day 7 hours ago

AMA Corp PLC : FY 2025 Earnings & Q1 2026 Revenue
Published on 04/30/2026 at 19:16, 1 day 8 hours ago

AXA announces the results of its Shareholders' Meeting
Published on 04/30/2026 at 19:00, 1 day 8 hours ago

Capital increase through exercise of subscription rights
Published on 04/30/2026 at 18:10, 1 day 9 hours ago

Minutes of the Combined General Meeting held on April 30, 2026
Published on 04/30/2026 at 18:00, 1 day 9 hours ago

TF1 Q1 2026 results - Press release

View all LES ECHOS COMFI WIRE

News